Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.86)
# 3,706
Out of 4,761 analysts
271
Total ratings
24.05%
Success rate
-24.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Maintains: Neutral | $20 → $18 | $10.81 | +66.59% | 4 | Feb 18, 2025 | |
| FEMY Femasys | Reiterates: Buy | $12 | $1.65 | +627.27% | 16 | Feb 11, 2025 | |
| RNAZ TransCode Therapeutics | Reiterates: Buy | $20 | $9.32 | +114.59% | 15 | Feb 7, 2025 | |
| ANAB AnaptysBio | Reiterates: Neutral | $19 | $19.36 | -1.83% | 7 | Feb 4, 2025 | |
| TNYA Tenaya Therapeutics | Reiterates: Buy | $18 | $1.11 | +1,521.62% | 1 | Feb 3, 2025 | |
| BCTX BriaCell Therapeutics | Maintains: Buy | $15 → $32 | $4.98 | +542.57% | 13 | Feb 3, 2025 | |
| ATOS Atossa Therapeutics | Reiterates: Buy | $7 | $0.85 | +719.48% | 12 | Jan 30, 2025 | |
| AGEN Agenus | Reiterates: Neutral | n/a | $3.48 | - | 13 | Jan 22, 2025 | |
| VTYX Ventyx Biosciences | Reiterates: Neutral | n/a | $1.67 | - | 15 | Jan 14, 2025 | |
| NVCR NovoCure | Reiterates: Buy | $38 | $21.77 | +74.59% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $6.25 | +540.00% | 8 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $11 | $3.11 | +254.27% | 9 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $6 | $2.20 | +173.35% | 13 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $0.90 | +1,233.33% | 11 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $5.06 | - | 16 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $64.55 | +78.16% | 12 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.64 | +241.56% | 3 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $3.31 | +896.98% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $4.81 | +524.26% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $9.62 | -6.44% | 10 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $6.06 | +263.04% | 10 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.10 | +990.91% | 11 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.77 | +422.19% | 6 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $18 | $2.15 | +737.21% | 14 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.79 | +663.75% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.94 | +751.97% | 4 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.33 | - | 1 | Apr 25, 2024 |
Arcus Biosciences
Feb 18, 2025
Maintains: Neutral
Price Target: $20 → $18
Current: $10.81
Upside: +66.59%
Femasys
Feb 11, 2025
Reiterates: Buy
Price Target: $12
Current: $1.65
Upside: +627.27%
TransCode Therapeutics
Feb 7, 2025
Reiterates: Buy
Price Target: $20
Current: $9.32
Upside: +114.59%
AnaptysBio
Feb 4, 2025
Reiterates: Neutral
Price Target: $19
Current: $19.36
Upside: -1.83%
Tenaya Therapeutics
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $1.11
Upside: +1,521.62%
BriaCell Therapeutics
Feb 3, 2025
Maintains: Buy
Price Target: $15 → $32
Current: $4.98
Upside: +542.57%
Atossa Therapeutics
Jan 30, 2025
Reiterates: Buy
Price Target: $7
Current: $0.85
Upside: +719.48%
Agenus
Jan 22, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.48
Upside: -
Ventyx Biosciences
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.67
Upside: -
NovoCure
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $21.77
Upside: +74.59%
Jan 10, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $6.25
Upside: +540.00%
Jan 8, 2025
Maintains: Buy
Price Target: $8 → $11
Current: $3.11
Upside: +254.27%
Jan 7, 2025
Maintains: Neutral
Price Target: $8 → $6
Current: $2.20
Upside: +173.35%
Dec 19, 2024
Reiterates: Buy
Price Target: $12
Current: $0.90
Upside: +1,233.33%
Dec 12, 2024
Reiterates: Buy
Price Target: n/a
Current: $5.06
Upside: -
Dec 10, 2024
Reiterates: Buy
Price Target: $115
Current: $64.55
Upside: +78.16%
Dec 10, 2024
Reiterates: Buy
Price Target: $9
Current: $2.64
Upside: +241.56%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $3.31
Upside: +896.98%
Nov 15, 2024
Maintains: Buy
Price Target: $32 → $30
Current: $4.81
Upside: +524.26%
Nov 15, 2024
Reiterates: Buy
Price Target: $9
Current: $9.62
Upside: -6.44%
Nov 14, 2024
Reiterates: Buy
Price Target: $22
Current: $6.06
Upside: +263.04%
Nov 12, 2024
Reiterates: Buy
Price Target: $12
Current: $1.10
Upside: +990.91%
Nov 11, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.77
Upside: +422.19%
Nov 11, 2024
Maintains: Buy
Price Target: $22 → $18
Current: $2.15
Upside: +737.21%
Sep 23, 2024
Reiterates: Buy
Price Target: $6
Current: $0.79
Upside: +663.75%
Sep 6, 2024
Reiterates: Buy
Price Target: $8
Current: $0.94
Upside: +751.97%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $4.33
Upside: -